The lack of AI incorporation within preclinical drug development, particularly in invivo pharmacological studies, restricts the healthcare sector in saving the time and lives of diverse species. This incorporation of AI should start from the school level rather than the reverse, to provide stability in the system.
#Invivo pharmacology